Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

Topic

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Articles

Biopharma companies on both sides of the Atlantic ship more of their assay testing to outside service providers.

Another In-House Operation Gets Outsourced

ProMetic Life Sciences will use manufacturing and plasma fractionation processes at Emergent BioSolutions’ Winnipeg, Canada facility.

Emergent BioSolutions, ProMetic Life Sciences Set Manufacturing Agreement

Clinical supplies facility in Frankfurt, Germany will triple Theorem Clinical Research’s current clinical supplies capacity.

Theorem Opens Clinical Supplies Facility

Grand River Aseptic Manufacturing named one of Michigan 50 Companies to watch.

Aseptic CMO Recognized as Company to Watch

This new pharmaceutical stability storage facility will enable the company to expand its analytical and formulation offerings to the pharmaceutical and biotech industries.

Intertek Opens GMP Pharmaceutical Stability Storage Facility in Cambridge, UK

EMA confirms its recommendation to suspend medicines approved based on GVK Biosciences studies.

EMA Upholds GVK Biosciences Suspension Recommendation

The use of disposables requires careful consideration and planning.

Disposable Technology versus Traditional Stainless Steel--When Time Means Money

FDA issues a Form 483 following inspection of Impax Laboratories' Hayward, CA facility.

Impax Laboratories Receives Form 483 Following FDA Inspection

Capsugel extends inhaled biotherapeutics delivery capability to Phase 2 clinical trials.

Capsugel Produces DPI Phase 2 Trial Supplies

While the United States and Europe still dominate, CMOs and CROs based in emerging markets continue to capture market share.